BioMAS Ltd.
🇮🇱Israel
Clinical Trials
6
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 2
5 (83.3%)Phase 1
1 (16.7%)Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital Warts
Phase 2
- Conditions
- External Genital Warts
- Interventions
- Drug: 15% AS101 gelDrug: Vehicle
- First Posted Date
- 2013-09-17
- Last Posted Date
- 2016-11-01
- Lead Sponsor
- BioMAS Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT01943630
- Locations
- 🇮🇱
Ha'Emek Medical Center, Department of Gynecology and obstetrics, Afula, Israel
🇮🇱Kaplan Medical Center, Department of Gynecology, Rehovot, Israel
🇮🇱Ziv Medical Center, Department of Gynecology and obstetrics, Safed, Israel
Safety and Efficacy Study to Test Topical AS101 for External Genital Warts
Phase 1
Completed
- Conditions
- Wart; External Genital OrgansCondyloma Acuminata
- Interventions
- Drug: Topical AS101
- First Posted Date
- 2012-03-15
- Last Posted Date
- 2013-08-15
- Lead Sponsor
- BioMAS Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT01555112
- Locations
- 🇮🇱
Gynecology department, Haemek MC, Afula, Israel
Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients
- First Posted Date
- 2009-11-10
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- BioMAS Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT01010373
- Locations
- 🇮🇱
Sheba Medical Center, Tel Hashomer, Israel
Topical Application of AS101 for the Treatment of Atopic Dermatitis
Phase 2
Terminated
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: AS101 ointment
- First Posted Date
- 2009-06-24
- Last Posted Date
- 2014-07-17
- Lead Sponsor
- BioMAS Ltd
- Target Recruit Count
- 5
- Registration Number
- NCT00927212
- Locations
- 🇮🇱
Dermatology department, Sheba Medical Center, Ramat-Gan, Israel
Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients
- First Posted Date
- 2009-06-23
- Last Posted Date
- 2011-06-21
- Lead Sponsor
- BioMAS Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT00926354
- Locations
- 🇮🇱
Meir Medical Center, Kfar Saba, Israel
- Prev
- 1
- 2
- Next
News
No news found